• Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News
Alcohol Use Disorder Alcohol Use Disorder
  • Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News

News

Hem » News
0

We are pleased to welcome Eva Hägglund as Clinical Project Director

READ MORE
0

New Board Member in Sobrera Pharma

READ MORE
0

SOBRERA PHARMA RECEIVES PATENT APPROVAL IN THE USA

The United States Patent and Trademark Office (USPTO) has granted a new patent US 11,318,143 further strengthening the Company’s Intellectual property position and coverage for the Company’s [...]

READ MORE
0

Recruitment Ongoing in the Phase II Study (COMB study)

READ MORE
0

Company Update – in Connection with the Annual General Meeting, June 10, 2021

Click below to read the presentation. Sobrera Update June 2021

READ MORE
 Sobrera Pharma receives patent approval in Europe
0

Sobrera Pharma receives patent approval in Europe

Sobrera Pharma AB is pleased to announce the Decisions to Grant on the European patent 3582764 titled ’Treatment of Alcohol Use’ by the European Patent Office (EPO). The decision to grant on the [...]

READ MORE
 Recruitment ongoing in the phase II study (COMB study).
0

Recruitment ongoing in the phase II study (COMB study).

Recruitment of patients to the phase II study (COMB study) is ongoing at the clinical study site in Gothenburg and in Stockholm. The study team is sharing information about the study including [...]

READ MORE
0

Anders Milton är ny styrelsemedlem i Sobrera Pharma AB

READ MORE
 Sobrera Pharma and Recipharm in collaboration to advance a new treatment for patients with Alcohol Use Disorder
0

Sobrera Pharma and Recipharm in collaboration to advance a new treatment for patients with Alcohol Use Disorder

Swedish life science company, Sobrera Pharma, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development and [...]

READ MORE
Sobrera Pharma AB
  • Erik Dahlbergsgatan 11A
    411 26 Göteborg
  • info@sobrera.com
Latest news & publications
  • We are pleased to welcome Eva Hägglund as Clinical Project Director 14 mars, 2023
  • New Board Member in Sobrera Pharma 11 oktober, 2022
  • SOBRERA PHARMA RECEIVES PATENT APPROVAL IN THE USA 30 juni, 2022
  • Recruitment Ongoing in the Phase II Study (COMB study) 27 januari, 2022
  • Company Update – in Connection with the Annual General Meeting, June 10, 2021 29 juni, 2021
Copyright All Rights Reserved © 2021
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search